Skip to main content

Pfizer–BioNTech vaccine appears to protect against U.K. and South African COVID-19 strains, study finds

BioNTech said that the company would be able to adjust the vaccine developed with Pfizer to address new mutations of a coronavirus if necessary.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.